Lung cancer was nowhere on her radar. "We're definitely seeing more and more, not only lung cancer, but really ...

Lung cancer researcher, Bryant Kin, has been diagnosed with the disease despite never smoking himself in his life, he's ...

"Immunotherapy for Non-Small Cell Lung Cancer." The Society of Thoracic Surgeons: “Lung/Thoracic Surgery.” Penn Medicine: “Photodynamic Therapy (PDT).” Journal of Thoracic Disease ...

Preliminary clinical data in post-anti-PD-1 NSCLC patients demonstrated a 27% ORR and 73% DCR in monotherapy trialMonotherapy activity with ...

Most non-small-cell lungcancer is caused by smoking, but your genes may also help determine your chances of getting the disease. Lung cancer is when cell growth in the lungs becomes abnormal and ...

In 33 heavily pretreated NSCLC EGFR wild-type (EGFRwt) patients the combination of AFM24 and atezolizumab shows an overall response rate (ORR) of ...

Gilead Sciences GILD announced that its first-in-class Trop-2-directed antibody-drug conjugate, Trodelvy (sacituzumab ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

More than 80% of patients with lung cancer receive care in their communities, but this can leave them vulnerable to gaps in care quality and delivery. Amivantamab's role in non–small cell lung ...